Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reversible decrease of dopamine D2 receptor density in the striatum of rats with acute hepatic failure.

J Waśkiewicz1, I Freśko, A Lenkiewicz

  • 1Laboratory of CNS Pathobiochemistry, Department of Neurochemistry, Medical Research Centre, Polish Academy of Sciences, Pawinskiego 5, 02-106, Warsaw, Poland.

Brain Research
|April 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amplitude Analysis of B^{±}→π^{±}K^{+}K^{-} Decays.

Physical review letters·2019
Same author

Search for the Lepton-Flavor-Violating Decays B_{s}^{0}→τ^{±}μ^{∓} and B^{0}→τ^{±}μ^{∓}.

Physical review letters·2019
Same author

Observation of New Resonances in the Λ_{b}^{0}π^{+}π^{-} System.

Physical review letters·2019
Same author

Measurement of CP-Violating and Mixing-Induced Observables in B_{s}^{0}→ϕγ Decays.

Physical review letters·2019
Same author

First Observation of the Radiative Decay Λ_{b}^{0}→Λγ.

Physical review letters·2019
Same author

Observation of an Excited B_{c}^{+} State.

Physical review letters·2019

This study investigated D2 receptor binding in rats with acute hepatic failure and hepatic encephalopathy (HE). D2 receptor binding decreased during HE symptoms but normalized and later increased during recovery, suggesting brain metabolic changes.

Area of Science:

  • Neuroscience
  • Hepatology
  • Pharmacology

Background:

  • Hepatic encephalopathy (HE) is a complex neurological complication of acute liver failure.
  • Dopamine D2 receptors are implicated in neurological functions and may be affected by HE.
  • Understanding receptor binding changes during HE is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the alterations in dopamine D2 receptor ([3H]spiperone binding) in rat striatal membranes during acute hepatic failure and subsequent recovery from hepatic encephalopathy (HE).

Main Methods:

  • Induction of acute hepatic failure in rats using thioacetamide (TAA).
  • Measurement of D2 receptor ligand ([3H]spiperone) binding in striatal membranes at different time points post-TAA administration.
  • Assessment of HE symptoms and biochemical correlates.

Related Experiment Videos

Main Results:

  • A significant 28% decrease in D2 receptor binding (Bmax) was observed during the symptomatic stage of HE (1 day post-TAA).
  • D2 receptor binding returned to control levels by 7 days post-TAA, coinciding with the absence of HE biochemical markers.
  • An increase in D2 receptor binding (31% above control) was noted at 21 days post-TAA, indicating metabolic brain activation during late recovery.

Conclusions:

  • Dopamine D2 receptor binding is dynamically altered during the course of acute hepatic failure and HE, decreasing during the symptomatic phase.
  • Receptor binding normalizes with HE resolution and subsequently increases during the recovery phase, suggesting adaptive brain metabolic changes.
  • These findings highlight the neurochemical shifts occurring in the brain during HE and its recovery, potentially offering targets for future interventions.